Skip to main content

Table 1 Baseline demographics, clinical characteristics, and outcomes

From: Establishment and validation of predictive model of ARDS in critically ill patients

  

Non-ARDS (n = 283)

ARDS (n = 117)

 

P value

Age, (year), median (Q1,Q3)

 

62.0 (50.0, 73.0)

66.0 (55.0, 76.0)

 

0.070

High (m), median (Q1,Q3)

 

1.68 (1.60, 1.72)

1.70 (1.63, 1.73)

 

0.215

Weight (kg), median (Q1,Q3)

 

68.0 (60.0, 75.0)

69.0 (60.0, 76.0)

 

0.641

BMI (kg/m2), median (Q1,Q3)

 

24.1 (21.5, 26.3)

23.9 (21.6, 26.7)

 

0.824

Gender (male), n (%)

 

159 (56.18)

86 (73.50)

 

0.001

Fluid intake

 

3084.0 (2703.5, 3991.0)

3413.00 (2788.0, 4346.0)

 

0.024

Fluid output

 

2800.00 (2032.50, 3601.00)

2608.00 (1915.00, 3460.00)

 

0.067

Fluid balance

 

2800.0 (2032.5, 3601.0)

2608.0 (1915.0, 3460.0)

 

< 0.01

Admission type, n (%)

 Planned surgical

 

87 (30.74)

21 (17.95)

 

0.024

E mergency surgical

 

141 (49.82)

65 (55.56)

 

 Medica

 

55 (19.43)

31 (26.50)

 

Comorbidities, n (%)

 COPD

 

6 (2.12)

2 (1.71)

 

1.000

 Hypertensive

 

129 (45.58)

60 (51.28)

 

0.299

 CAD

 

30 (10.60)

19 (16.24)

 

0.118

 DM

 

61 (21.55)

29 (24.79)

 

0.481

 Hepatic disease

 

33 (11.66)

29 (24.79)

 

< 0.001

 Tumor

 

39 (13.78)

24 (20.51)

 

0.093

 CKD

 

12 (4.24)

7 (5.98)

 

0.456

Laboratory variables median (IQR)

 HGB

 

113.0 (94.0,128.0)

114.0 (92.0, 131.0)

 

0.952

 NLR

 

9.8 [5.4,18.3]

9.6 [5.1,18.50]

 

0.991

 RDW_CV

 

13.3 (12.7, 14.6)

13.9 (12.9, 14.8)

 

0.054

 Lactate

 

2.0 (1.4, 3.4)

2.3 (1.5, 4.0)

 

0.084

 INR

 

1.2 (1.1, 1.4)

1.3 (1.2 1.5)

 

0.009

 UREA

 

6.7(4.8, 10.2)

8.7 (6.0, 12.6)

 

< 0.001

 ALB

 

28.0 (23.8 32.1)

27.6 (23.3, 30.5)

 

0.319

Diagnose n (%)

 Shock

 

100 (35.34)

81 (69.23)

 

< 0.01

 Trauma

 

36 (12.72)

19 (16.24)

 

0.353

 Brain injury

 

67 (23.67)

20 (17.09)

 

0.147

 Sepsis

 

97 (34.28)

65 (55.56)

 

< 0.01

 Acute abdomen

 

102 (36.04)

64 (54.70)

 

< 0.001

 Lung contusion

 

6 (2.12)

15 (12.82)

 

< 0.001

 Pneumonia

 

21 (7.42)

24 (20.51)

 

< 0.001

 Aspiration

 

0 (0.4)

7 (6.0)

 

< 0.001

 Orthopedic spine

 

36 (12.72)

6 (5.13)

 

0.024

 SCI

 

51 (18.02)

9 (7.69)

 

0.008

Advanced life support n (%)

 MBT

 

3 (1.06)

5 (4.27)

 

0.090

 Vasoactive drugs

 

184 (65.02)

97 (82.91)

 

< 0.001

 CRRT

 

38 (13.43)

33 (28.21)

 

< 0.001

Score median (Q1,Q3)

 APACHE II

 

17.0 (13.0, 19.0)

19.0 (16.0, 22.0)

 

< 0.001

 LIPS

 

5.5 (3.5, 7.0)

8.5 (6.5, 10.0)

 

< 0.001

 SOFA

 

6.0 (4.0, 8.0)

8.0 (6.0, 10.0)

 

< 0.001

  1. ARDS: acute respiratory distress syndrome NLR: Neutrophil-to-Lymphocyte Ratio; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; BMI: body mass index; COPD: chronic obstructive pulmonary disease; CAD: coronary artery disease; DM: diabetes mellitus; CKD: chronic kidney disease; MBT: massive blood transfusion; CRRT: continuous renal replacement therapy; SCI: spinal cord injury; HGB: hemoglobin; RDW_CV:Coefficient of variation of red cell distribution width; INR: international normalized ratio; ALB: albumin;
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us